Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples.
Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples.
复制标题
DOI:
10.1002/ajmg.b.31006
复制
发表时间:
2010-03-05
影响因子:
2.8
通讯作者:
Everall, Ian P.
中科院分区:
文献类型:
--
作者:
Bousman, Chad A.;Chana, Gursharan;Glatt, Stephen J.;Chandler, Sharon D.;Lucero, Ginger R.;Tatro, Erick;May, Todd;Lohr, James B.;Kremen, William S.;Tsuang, Ming T.;Everall, Ian P.
Schizophrenia (SCZ) and bipolar disorder (BPD) are polygenic disorders with many genes contributing to their etiologies. The aim of this investigation was to search for dysregulated molecular and cellular pathways for these disorders as well as psychosis. We conducted a blood-based microarray investigation in two independent samples with SCZ and BPD from San Diego (SCZ = 13, BPD = 9, control = 8) and Taiwan (SCZ = 11, BPD = 14, control = 16). Diagnostic groups were compared to controls, and subjects with a history of psychosis [PSYCH(+): San Diego (n = 6), Taiwan (n = 14)] were compared to subjects without such history [PSYCH(−): San Diego (n = 11), Taiwan (n = 14)]. Analyses of covariance comparing mean expression levels on a gene-by-gene basis were conducted to generate the top 100 significantly dysregulated gene lists for both samples by each diagnostic group. Gene lists were imported into Ingenuity Pathway Analysis (IPA) software. Results showed the ubiquitin proteasome pathway (UPS) was listed in the top ten canonical pathways for BPD and psychosis diagnostic groups across both samples with a considerably low likelihood of a chance occurrence (P = 0.001). No overlap in dysregulated genes populating these pathways was observed between the two independent samples. Findings provide preliminary evidence of UPS dysregulation in BPD and psychosis as well as support further investigation of the UPS and other molecular and cellular pathways for potential biomarkers for SCZ, BPD, and/or psychosis.
登录
查看更多内容
影响因子:
--
作者:
Schroeder A;Mueller O;Stocker S;Salowsky R;Leiber M;Gassmann M;Lightfoot S;Menzel W;Granzow M;Ragg T
通讯作者:
Ragg T
影响因子:
3.7
作者:
Huang JT;Leweke FM;Tsang TM;Koethe D;Kranaster L;Gerth CW;Gross S;Schreiber D;Ruhrmann S;Schultze-Lutter F;Klosterkötter J;Holmes E;Bahn S
通讯作者:
Bahn S
DOI:
10.1073/pnas.032069099
发表时间:
2002-04-02
影响因子:
11.1
作者:
Mimmack, ML;Ryan, M;Bahn, S
通讯作者:
Bahn, S
影响因子:
--
作者:
Merikangas, Kathleen R.;Akiskal, Hagop S.;Kessler, Ronald C.
通讯作者:
Kessler, Ronald C.
影响因子:
168.9
作者:
Tkachev, D;Mimmack, ML;Bahn, S
通讯作者:
Bahn, S